Skip to main content

Table 1 Baseline participant characteristics in CFAS I and CFAS II

From: Increasing prevalence of anticholinergic medication use in older people in England over 20 years: cognitive function and ageing study I and II

Demographic characteristics

CFAS I (N = 7,635)

CFAS II (N = 7,762)

Sex

 Male

3045 (39.9)

3534 (45.5)

 Female

4590 (60.1)

4228 (54.5)

Age

 64–69

1981 (25.9)

1939 (25.0)

 70–74

1776 (23.3)

1873 (24.1)

 75–79

1725 (22.6)

1624 (20.9)

 80–84

1308 (17.1)

1278 (16.5)

 85–89

615 (8.1)

737 (9.5)

 90+

230 (3.0)

311 (4.0)

Centre

 Cambridgeshire

2601 (34.1)

2558 (33.0)

 Newcastle

2522 (33.0)

2582 (33.3)

 Nottingham

2512 (32.9)

2622 (33.8)

MMSE1

 Median (IQR)

27 (24, 28)

28 (26, 29)

Disability

 None

5236 (68.6)

4975 (64.1)

 IADL disability

1048 (13.7)

1495 (19.3)

 ADL-IADL disability

1267 (16.6)

981 (12.6)

Residence

 Community-dwelling

7245 (94.9)

7565 (97.5)

 Long term care

242 (3.2)

197 (2.5)

  1. Cell entries denote n (%) unless otherwise specified
  2. 1139 and 255 participants had missing MMSE data in CFAS I and CFAS II
  3. Abbreviations: CFAS Cognitive Function and Ageing Studies, CI confidence interval, MMSE Mini-Mental State Examination, ADL activities of daily living, IADL instrumental activities of daily living, SD standard deviation, IQR Interquartile range